In the pharma industry, key opinion leaders (KOLs) can significantly influence the consumer purchasing decision, as they have invested time and research to be recognised by their peers as e
Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist.